Ref.: BL-RE-143466Manufacturer ref.: EP19RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.
The urokinase-type plasminogen activator receptor is a key molecule in regulating the activation of cell surface plasminogen and plays an important role in many normal and pathological processes. I'll be right back.
The urokinase-type plasminogen activator receptor is a key molecule in regulating the activation of cell surface plasminogen and plays an important role in many normal and pathological processes. I'll be right back.
The urokinase-type plasminogen activator receptor is a key molecule in regulating the activation of cell surface plasminogen and plays an important role in many normal and pathological processes. Human code 335 amino acids, including a signal peptide of 22 predicted residues and a portion at C hydrophobic termination. It produces a highly glycosylated protein of about 50 kD in monocytes where it is anchored to the plasma membrane by glycosyl-phosphatidylinositol bond. PLAUR, also known as d的UPAR, is directly associated with the SELL carbohydrate binding domain in the neutrophil membrane, an association similar to that between PLAUR and beta-2 integrins. Calcium mobilization at PLAUR is dependent on SELL. The levels of d-mRNA UPAR are correlated with the invasive potential of l-endome carcinomas and show an x 33 increase in the levels of d-mRNA UPAR in endometrial tumours of advanced clinical stage compared to normal endometrial tissues. In addition, the increase in mRNA levels of UPAR is linearly correlated with the progression of the disease stage. The protein expression of the UPAR is positively correlated with the rate of recurrence and mortality in patients with l'endometrial cancer. The UPAR appears to be a useful prognostic marker for advanced l-endometrial cancer.
Sensitivity
Sensitivity of the dosage: 0.12 ng/ml.
Measurement range
Dosing range: 0.12 to 25 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Target
Target: uPAR (CD87).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17708173
Specifications
Accession number
P12247
Dose range
0.12 to 25 ng/ml
Sensitivity of the dosage
0.12 ng/ml
Conjugate
Biotin
Product type
ELISA
Type of sample
Plasma, Serum, Surnatant
For use with (equipment)
Colorimetric microplate reader
Genetic identification (Enter)
100009121
Gene symbol(s)
C3
Coefficient of inter-dose variation
< 12%
Coefficient of intra-dose variation
< 10%
Contents of kits
96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dye
HRP
Quantity
10 x 96 tests
Regulatory status
RUO
Target
uPAR (CD87)
Test time
1 h 20 min
Physical characteristics
Volume of sample
Supernatant, 50 μl-Plasma, 50 μl-Sera, 50 μl
Storage and shipping
Storage conditions
2°C to 8°C
Total duration of dosing
4 h 45 min
Origin and customs
Manufacturer ref.
EP19RBX10
Country of origin
United States
HS customs code
3002 12 00 00
A question or a specific configuration? Contact us for a quote.